137 related articles for article (PubMed ID: 22644092)
21. Efficacy and Safety of Tacrolimus versus Cyclosporine A for Idiopathic Membranous Nephropathy:A Network Meta-analysis.
Xu P; He YD; Yu ZM; Luo K; Xie HY; Zou PM; Gu X; Wang SR; Cai JF; Xu Q; Li H; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):41-51. PubMed ID: 29532780
[TBL] [Abstract][Full Text] [Related]
22. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
24. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
25. Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy.
Aaltonen S; Honkanen E
Nephrol Dial Transplant; 2011 Sep; 26(9):2871-7. PubMed ID: 21427071
[TBL] [Abstract][Full Text] [Related]
26. [The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy].
Xia W; Pei H; Li S; Fu S; Tian L
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):181-5. PubMed ID: 26926368
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
[TBL] [Abstract][Full Text] [Related]
28. A difficult trade off for adults with membranous nephropathy.
BMJ; 2013 Jan; 346():f248. PubMed ID: 23325868
[No Abstract] [Full Text] [Related]
29. Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen.
Hassan K; Kristal B
Minerva Urol Nefrol; 2016 Jun; 68(3):293-301. PubMed ID: 25645342
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[TBL] [Abstract][Full Text] [Related]
31. [Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review].
Zotta F; Di Stasio E; Manzione A; Pirozzi N; Stoppacciaro A; Menè P
G Ital Nefrol; 2019 Jun; 36(3):. PubMed ID: 31251003
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[TBL] [Abstract][Full Text] [Related]
33. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
34. Membranous nephropathy: when and how to treat.
Lai KN
Kidney Int; 2007 May; 71(9):841-3. PubMed ID: 17457329
[TBL] [Abstract][Full Text] [Related]
35. Treatment of progressive renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
Baker LR; Tucker B; Macdougall IC; Oommen R
Nephrol Dial Transplant; 1998 Oct; 13(10):2704. PubMed ID: 9794596
[No Abstract] [Full Text] [Related]
36. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.
Cattran DC
Semin Nephrol; 2003 May; 23(3):272-7. PubMed ID: 12838495
[TBL] [Abstract][Full Text] [Related]
38. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
39. Tonsillar Kaposi sarcoma in a patient with membranous glomerulonephritis on immunosuppressive therapy.
Al-Brahim N; Zaki AH; El-Merhi K; Ahmad MS
Ear Nose Throat J; 2013 Jul; 92(7):E1-4. PubMed ID: 23904308
[TBL] [Abstract][Full Text] [Related]
40. Treatment of idiopathic membranous nephropathy (IMN).
Alexopoulos E; Papagianni A
Ren Fail; 2000 Nov; 22(6):697-709. PubMed ID: 11104159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
